Latest on the Virus
Markets
Spotlight
August 16, 2026
World
PMV’s $79.4m cash pile now hinges on rezatapopt’s 2027 ovarian cancer FDA bid
PMV completes key rezatapopt enrollment with a 2027 FDA filing ahead as its $79.4m cash balance exceeds its current market value.
NFI Group’s backlog shrank 10.6% as earnings surged. How can both be true?
NFI's backlog shrank, but firm orders grew, margins improved and guidance rose. Here is what the option decline means for NFI stock.
Frontera Energy (TSX: FEC) Q2 puts early-2027 LNG launch in focus
Frontera is now an infrastructure company after returning C$590m. Can Puerto Bahía LNG and ODL cash flow drive FEC's next growth phase?